Patents Assigned to Epicrispr Biotechnologies, Inc.
  • Engineered nucleases, compositions, and methods of use thereof
    Patent number: 12054756
    Abstract: The present disclosure provides one or more engineered nucleases and systems, compositions, and methods thereof, wherein the one or more engineered nucleases can be used to effect binding, cleaving, and/or editing a target polynucleotide sequence. The one or more engineered nucleases can be engineered variants of a small CRISPR/Cas protein.
    Type: Grant
    Filed: July 7, 2023
    Date of Patent: August 6, 2024
    Assignee: Epicrispr Biotechnologies, Inc.
    Inventors: Xiao Yang, Lei S. Qi, Vincent Cutillas, Gabriella Alvarez, Tabitha Tcheau, Daniel O. Hart